Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or side effect disclosures. These compounded drugs, unlike generics, are not ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Unopened compounded semaglutide lasts in the fridge until the expiration date shown on the vial. But after it’s opened, compounded semaglutide only lasts in the fridge for 28 days. If you haven ...

She was prescribed compound semaglutide, a cheaper, custom-made version of the active drug in Ozempic and Wegovy, in May 2022 and lost a staggering 64lbs in six months. But then she made a big ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

issued an alert warning doctors and patients about dosing errors involving compounded semaglutide injectable products that were dispensed in multiple-dose vials. The health regulator said it had ...

The weight loss drug semaglutide was a "miracle" for Staci Rice. Her cravings and "food noise" disappeared, and it help her lose 64 pounds in around eight months. But, even in its cheaper forms ...

Rybelsus is an oral tablet best taken on an empty stomach. Avoiding certain types of food in your diet may help manage blood sugar levels and minimize certain side effects of the drug. Limiting ...

But the semaglutide-like drugs also appear to increase the risk of many others. Glucagon-like peptide 1 receptor agonists (called simply GLP-1RAs), the class to which those drugs and others including ...

Treatment with once-weekly semaglutide 7.2 mg conferred a 20.7% weight reduction vs. a 17.5% weight loss with semaglutide 2.4 mg. The safety profile of semaglutide 7.2 mg is similar to other GLP-1s.

Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor agonist semaglutide in adults with obesity. The phase 3b STEP UP trial has been ...